StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a report released on Sunday. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Price Performance Shares of NYSE:BTX opened at $1.15 on Friday. Brooklyn ImmunoTherapeutics has a one year low of $0.17 and a one year high of $10.10. […]